Kura Oncology, Inc., and Kyowa Kirin Co., Ltd. announced Kura submitted a New Drug Application (NDA) for ziftomenib, a highly selective, once-daily, oral, investigational menin inhibitor, for the treatment of…
In a landmark move that underlined the growing convergence between international development…
Olympus Corporation has launched the NBI+TXI™ observation mode. This new feature enhances…
Ajinomoto Bio-Pharma Services (Aji Bio-Pharma) and Olon S.p.A. are teaming up. This…
Japanese-made robotic surgery is on the rise—unlocking new opportunities for Japan's tech…
Amato Pharmaceutical Co., Ltd., a pharmaceutical manufacturer with over 200 years of…
Terumo Interventional Systems (TIS), a part of Terumo Corporation, announced that the…
Logistics Knight Japan Inc., Isuzu Motors Limited, and Fujitsu Limited will begin…
アカウントにサインインする